ABCL
Abcellera Biologics Inc
13.90$
-4.7%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 70.5% | 53.8% | 80.9% | 70.5% | 66.6% | 58.6% | 55.2% | 53.7% | |
| 48.6% | 32.2% | 59.1% | 36.1% | 25.1% | 9.0% | 11.5% | 9.5% | |
| 48.6% | 32.2% | 59.1% | 54.8% | 57.5% | 51.1% | 46.0% | 39.3% | |
| 6.5% | 9.0% | 21.3% | 13.3% | 6.7% | 4.3% | 6.8% | 11.3% | |
| 0.0% | 0.7% | 0.1% | 0.1% | 0.1% | 0.1% | 0.0% | 0.5% | |
| 29.5% | 36.1% | 1.8% | 8.5% | 14.1% | – | – | – | |
| – | – | 3.1% | 3.6% | 3.1% | 3.2% | 3.5% | 3.5% | |
| – | – | 11.5% | 11.3% | 8.5% | 8.1% | 3.1% | 2.8% | |
| 46.0% | 56.4% | 17.4% | 22.2% | 20.0% | 22.6% | 22.4% | 28.7% | |
| 29.9% | 33.6% | 10.3% | 9.2% | 7.7% | 8.0% | 5.6% | 4.7% | |
| 11.8% | 12.3% | 0.1% | 0.3% | 0.4% | 0.4% | 0.3% | 0.4% | |
| 7.1% | 7.0% | 0.7% | 1.1% | 1.0% | 1.7% | 2.5% | 1.9% | |
| 4.2% | 5.8% | 0.2% | – | – | – | – | – | |
| 54.0% | 43.6% | 82.6% | 77.8% | 80.0% | 77.4% | 77.6% | 71.3% | |
| -11.7% | -20.1% | 11.4% | 20.3% | 27.7% | 18.8% | 8.6% | -2.2% | |
| 702.8% | 1,012.1% | 26.2% | 24.1% | 20.4% | 19.4% | 21.6% | 22.0% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.